Trade Summary

2 days ago, Edgemond James, serving as CFO, TREASURER at United Therapeutics Corp (UTHR), sold 10,000 shares at $574.48 per share, for a total transaction value of $5,744,746.00. Following this transaction, Edgemond James now holds 18,876 shares of UTHR.

This sale represents a 35.00% decrease in Edgemond James's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 14, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 15, 2026 at 5:04 PM ET, 1 day after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.